Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

GlycoDesign seeking licensees for its carbohydrate-processing inhibitor GD0039

June 3, 1998

Vinflunine, a vinca alkaloid with more potent activity than vinorelbine in preclinical models

June 2, 1998

FDA advisory committee recommends expanded use of Taxotere

June 2, 1998

Liarozole, a RAMBA with clinical efficacy in treating prostate cancer

June 2, 1998

Sparta receives FDA approval for phase II/III trials of Spartaject busulfan

June 2, 1998

Agents for tumors and tumor metastasis synthesized at Ishihara Sangyo

June 1, 1998

Protein tyrosine or serine/threonine kinase inhibitors in development at Novartis

June 1, 1998

Imutech and Harvard Medical School join forces for clotrimazole development

June 1, 1998

New protein farnesyltransferase inhibitors prepared by Zeneca

June 1, 1998

Somatostatin analogue TT-232 prevents proliferation of pancreatic cancer

May 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...